ISRCTN79708370已完成不适用
Value of Comprehensive Geriatric Assessment, clinical judgment, and performance status in the treatment of patients with epithelal ovarian carcinoma aged 70 years and older
TweeSteden Hospital (The Netherlands)0 个研究点目标入组 60 人开始时间: 2007年2月26日最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 已完成
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 性别
- Female
入选标准
- •1. Histological confirmed (extra) epithelial ovarian carcinoma International Federation of Gynaecology and Obstetrics (FIGO) grade IIB - IV. Tumours of borderline malignancy are excluded.
- •2. No prior treatment with cytostatic agents or radiotherapy
- •3. Age greater than or equal to 70 years
- •4. Eastern Cooperative Oncology Group (ECOG) performance status zero to two
- •5. Life expectancy greater than or equal to three months
- •6. Able to undergo protocol treatment according to clinical judgment of the medical oncologist
- •7. No second primary malignancy except for adequately treated in situ carcinoma of the cervix uteri, basal or squamous cell carcinoma of the skin, or a prior cancer cured with surgery alone and with a disease-free interval of longer than five years
- •8. Adequate haematological, renal and hepatic function as defined by the following required laboratory values (obtained less than or equal to 14 days prior to study enrolment):
- •8.1. White blood cells (WBC) greater than or equal to 3.0 x 10^9/L
- •8.2. Platelets greater than or equal to 100 x 10^9/L
- •8.3. Calculated creatinine clearance greater than or equal to 40 ml/min (according to the Cockroft and Gault formula)
- •8.4. Serum bilirubin less than or equal to 1.5 x upper normal limit
- •8.5. Serum glutamic oxaloacetic transaminase (SGOT) (aspartate aminotransferase [AST]) and/or serum glutamic pyruvic transaminase (SGPT) (alanine aminotransferase [ALT]) less than or equal to 2.5 x upper normal limit
- •9. Absence of significant cardiac disease, i.e. uncontrolled high blood pressure, unstable angina, congestive heart failure, myocardial infarction within the previous year, or cardiac ventricular arrhythmias requiring medication. History of second and third degree heart blocks without pacemaker in situ.
- •10. No active infection, major medical illness, signs or symptoms of central nervous system (CNS) involvement or leptomeningeal disease
- •11. No known hypersensitivity reactions to any of the components of the treatment, including cremophor
- •12. Absence of common toxicity criteria (CTC) grade greater than or equal to one peripheral neurotoxicity
- •13. Assessable for treatment and follow-up
- •14. Informed consent
排除标准
- •Does not comply with the above inclusion criteria
研究者
相似试验
已完成
不适用
Comprehensive Geriatric Assessment study to determine an appropriate therapy for elderly patients with diffuse large B-cell lymphomaDiffuse large B-cell lymphomaJPRN-UMIN000025231Fukuoka University Division of Medical Oncology, Hematology and Infectious Disease150
尚未招募
不适用
Comprehensive geriatric assessment and interventions in older lung cancer patientsung CancerElderlyACTRN12618000794202niversity of Melbourne150
尚未招募
Unknown
to determine whether radiation to older cancer patients have any side effects to their health both physical and mentalCTRI/2024/01/062149nil
已完成
不适用
Value of Comprehensive Geriatric Assessment, clinical judgment, and performance status in the treatment of patients with epithelal ovarian carcinoma aged 70 years and older.Ovarian cancer FIGO IIB-IVNL-OMON23843TweeSteden hospital, location Tilburg60
招募中
Unknown
The role of comprehensive geriatric assessment in older patients affected by knee osteoarthritisM13Other arthritisKnee OsteoarthritisDRKS00031979niversität Palermo, Forschung in der Abteilung für Geriatrie, Abteilung für Innere Medizin und Geriatrie60